{"id":63072,"date":"2026-05-07T13:02:22","date_gmt":"2026-05-07T11:02:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/"},"modified":"2026-05-07T13:02:22","modified_gmt":"2026-05-07T11:02:22","slug":"causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/","title":{"rendered":"causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization"},"content":{"rendered":"<div>\n<p>LONDON&#8211;(BUSINESS WIRE)&#8211;causaLens, a London-based AI scaleup, today announced the expansion of its strategic partnership with <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.syneoshealth.com%2Fai%3Futm_source%3DPR%26utm_medium%3Dmedia-release%26utm_campaign%3DSyneos_Health_AI_2026%26utm_content%3DcausaLens&amp;esheet=54529457&amp;newsitemid=20260506514597&amp;lan=en-US&amp;anchor=Syneos+Health&amp;index=1&amp;md5=2aa0ef290165b96e9a22a836a2f9341b\" rel=\"nofollow\" shape=\"rect\">Syneos Health<\/a>, a leading fully integrated biopharmaceutical solutions organization, to advance the industry\u2019s shift toward faster, more intelligent and scalable commercialization.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20260506514597\/en\/2795650\/5\/logo_causaLens_save.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260506514597\/en\/2795650\/22\/logo_causaLens_save.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20260506514597\/en\/2795650\/5\/logo_causaLens_save.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260506514597\/en\/2795650\/21\/logo_causaLens_save.jpg\"><\/a><\/p>\n<p>\nThe companies initially partnered to execute advanced causal AI models to optimize commercial programs, pivoting from time-intensive data science tools to faster, AI-driven decision-making to speed business outcomes.<\/p>\n<p>\nBuilding upon that foundation, Syneos Health has now deployed causaLens digital workers (multi-agentic systems) into the company\u2019s operations \u2013 the industry\u2019s broadest integrated commercial suite \u2013 to transform how commercial insights are generated and applied to drive customer value. causaLens digital workers use causal reasoning tools, making them uniquely equipped to deliver trusted, explainable and production-ready insights in high-stakes, highly regulated environments, including pharmaceuticals and healthcare.<\/p>\n<p>\n\u201cBy combining causal reasoning, a field we pioneered, with multi-agent automation, we\u2019re helping Syneos Health translate complex data into meaningful commercial action for biopharma brands,\u201d said Darko Matovski, CEO, causaLens. \u201cWith decision-ready answers at the fingertips of their expansive Commercial teams, this partnership positions Syneos Health as one of the most agile, efficient and future-ready service providers in the market.\u201d<\/p>\n<p>\ncausaLens\u2019 Platform drives commercial value for brands of all sizes by enabling faster and more confident decisions across planning and execution \u2013 from identifying and prioritizing the right healthcare provider (HCP) audiences to continuously optimizing channel mix, territories and media. Capabilities currently include:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nHCP target identification and scoring<\/li>\n<li>\nHCP engagement optimization<\/li>\n<li>\nSales territory design and planning<\/li>\n<li>\nDigital media campaign execution, and ongoing monitoring and optimization<\/li>\n<\/ul>\n<p>\n\u201cWith causaLens, we\u2019re scaling intelligent automation and data science across the organization and driving precision performance that optimizes what works, predicts what matters and automates execution,\u201d said Stephen Hoelper, Global Head, Commercial Product, Syneos Health. \u201ccausaLens digital workers are transforming how our teams work, providing insights that have the ability to accelerate launch, adoption and growth for our biopharmaceutical customers.\u201d<\/p>\n<p>\n<b>About causaLens<\/b><\/p>\n<p>\ncausaLens delivers Digital Workers that enterprises can rely on. Enterprises that have adopted digital workers have superior margins and products.<\/p>\n<p>\nWe&#8217;ve built the first system for creating, deploying, and governing Digital Workers.<\/p>\n<p>\nFor too long, enterprises have been bogged down by repetitive work, an overload of tools, and costly consultancies.<\/p>\n<p>\nIt&#8217;s time to simplify.<\/p>\n<p>\nIt&#8217;s time for Digital Workers to take on the repetitive workflows, enabling humans to focus on what matters most.<\/p>\n<p>\nTrusted by leading companies like J&amp;J, Cisco, IPG Group, and Syneos Health.<\/p>\n<p>\nBacked by over $50M in funding from world-class investors, including Molten Ventures (formerly Draper Esprit), Dorilton Capital, and IQ Capital plus visionary angel investors such as the CEO of Revolut.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nFelix Mottram, 07751763777, <a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#58;&#x66;e&#108;&#x69;x&#64;&#x63;&#97;&#x75;&#x73;&#97;&#x6c;&#x65;&#110;&#x73;&#46;&#99;&#x6f;m\" rel=\"nofollow\" shape=\"rect\">&#x66;e&#x6c;&#105;&#x78;&#64;&#x63;&#x61;u&#x73;&#97;&#x6c;&#101;&#x6e;&#115;&#46;&#x63;&#111;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>LONDON&#8211;(BUSINESS WIRE)&#8211;causaLens, a London-based AI scaleup, today announced the expansion of its strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical solutions organization, to advance the industry\u2019s shift toward faster, more intelligent and scalable commercialization. The companies initially partnered to execute advanced causal AI models to optimize commercial programs, pivoting from time-intensive data science &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-63072","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LONDON&#8211;(BUSINESS WIRE)&#8211;causaLens, a London-based AI scaleup, today announced the expansion of its strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical solutions organization, to advance the industry\u2019s shift toward faster, more intelligent and scalable commercialization. The companies initially partnered to execute advanced causal AI models to optimize commercial programs, pivoting from time-intensive data science ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-07T11:02:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260506514597\/en\/2795650\/22\/logo_causaLens_save.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization\",\"datePublished\":\"2026-05-07T11:02:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/\"},\"wordCount\":461,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260506514597\\\/en\\\/2795650\\\/22\\\/logo_causaLens_save.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/\",\"name\":\"causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260506514597\\\/en\\\/2795650\\\/22\\\/logo_causaLens_save.jpg\",\"datePublished\":\"2026-05-07T11:02:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260506514597\\\/en\\\/2795650\\\/22\\\/logo_causaLens_save.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260506514597\\\/en\\\/2795650\\\/22\\\/logo_causaLens_save.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/","og_locale":"en_US","og_type":"article","og_title":"causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization - Pharma Trend","og_description":"LONDON&#8211;(BUSINESS WIRE)&#8211;causaLens, a London-based AI scaleup, today announced the expansion of its strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical solutions organization, to advance the industry\u2019s shift toward faster, more intelligent and scalable commercialization. The companies initially partnered to execute advanced causal AI models to optimize commercial programs, pivoting from time-intensive data science ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/","og_site_name":"Pharma Trend","article_published_time":"2026-05-07T11:02:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260506514597\/en\/2795650\/22\/logo_causaLens_save.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization","datePublished":"2026-05-07T11:02:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/"},"wordCount":461,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260506514597\/en\/2795650\/22\/logo_causaLens_save.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/","url":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/","name":"causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260506514597\/en\/2795650\/22\/logo_causaLens_save.jpg","datePublished":"2026-05-07T11:02:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260506514597\/en\/2795650\/22\/logo_causaLens_save.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260506514597\/en\/2795650\/22\/logo_causaLens_save.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/causalens-expands-strategic-partnership-with-syneos-health-to-scale-agentic-ai-in-biopharma-commercialization\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=63072"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63072\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=63072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=63072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=63072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}